Jan 17, 2025 · “Improving prescription drug affordability for Medicare enrollees is the core of the Inflation Reduction Act, and the next cycle of negotiations will continue to strengthen Medicare …

Jan 17, 2025 · The government can't pick just any drugs to target for price negotiation. There are certain rules laid out in the Inflation Reduction Act that say which drugs in Medicare are eligible.

Sep 23, 2024 · Novo Nordisk's blockbuster diabetes drug Ozempic will be eligible for U.S. government's price negotiations in less than a year based on current criteria, the Danish …

Jan 17, 2025 · WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly …

Jan 17, 2025 · The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next …

Jan 17, 2025 · Eli Lilly’s CEO Dave Ricks told Bloomberg News earlier this week that manufacturers will ask the incoming administration to pause the negotiations to “fix” the …

Jan 17, 2025 · The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.

Jan 17, 2025 · The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. ... dozen other widely used or costly medications as part of a program created by the …

May 29, 2024 · The Inflation Reduction Act put a $35-a-month limit on what seniors with Medicare Part D plans need to pay for insulin.

Feb 15, 2024 · Novo Nordisk boosted the list price of Ozempic by 3.5% to $969 for a four-week supply. The company told CNN that it increases the list prices of some medications each year …